Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Influenza Other Respir Viruses ; 15(2): 181-187, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33280235

RESUMO

We assessed EV-D68 epidemiology and phylogenetics among children aged ≤9 years hospitalized with severe acute respiratory illnesses at five sites in Panama and El Salvador during 2012-2013. Respiratory specimens positive for enterovirus or rhinovirus were tested by real-time RT-PCR for EV-D68, and partial VP1 gene sequences were determined. Of 715 enrolled children, 17 from sites in both countries were EV-D68-positive and commonly had a history of asthma or wheezing. Phylogenetically, 15 of 16 sequences fell into Clade B1, and one into Clade A2. The Central American EV-D68s were closely related genetically to contemporaneous strains from North America, South America, and the Caribbean.


Assuntos
Enterovirus Humano D , Infecções por Enterovirus , Infecções Respiratórias , Criança , Criança Hospitalizada , Surtos de Doenças , El Salvador/epidemiologia , Enterovirus Humano D/genética , Infecções por Enterovirus/epidemiologia , Humanos , Lactente , Panamá/epidemiologia , Infecções Respiratórias/epidemiologia
2.
Lancet Glob Health ; 8(4): e497-e510, 2020 04.
Artigo em Inglês | MEDLINE | ID: mdl-32087815

RESUMO

BACKGROUND: Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018. METHODS: We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries. FINDINGS: In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1-190·6), 10·1 million influenza-virus-associated ALRI cases (6·8-15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000-1 415 000), 15 300 in-hospital deaths (5800-43 800), and up to 34 800 (13 200-97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries. INTERPRETATION: A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries. FUNDING: WHO; Bill & Melinda Gates Foundation.


Assuntos
Saúde Global/estatística & dados numéricos , Influenza Humana/complicações , Infecções Respiratórias/epidemiologia , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Modelos Lineares , Estações do Ano
3.
J Infect ; 79(2): 108-114, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31153920

RESUMO

BACKGROUND AND OBJECTIVES: Although acute respiratory illness (ARI) is a leading cause of hospitalization among young children, few data are available about cost of hospitalization in middle-income countries. We estimated direct and indirect costs associated with severe ARI resulting in hospitalization among children aged <10 years in El Salvador and Panama through the societal perspective. METHODS: During 2012 and 2013, we surveyed caregivers of children hospitalized with ARI about their direct medical (i.e., outpatient consultation, medications, hospital fees), non-medical (transportation, childcare), and indirect costs (lost wages) at discharge and 7 days after discharge. We multiplied subsidized hospital bed costs derived from administrative data by hospitalization days to estimate provider costs. RESULTS: Overall, 638 children were enrolled with a median age of 12 months (IQR 6-23). Their median length of hospitalization was 4 days (IQR 3-6). In El Salvador, caregivers incurred a median of US$38 (IQR 22-72) in direct and indirect costs per illness episode, while the median government-paid hospitalization cost was US$118 (IQR 59-384) generating an overall societal cost of US$219 (IQR 101-416) per severe ARI episode. In Panama, caregivers incurred a median of US$75 (IQR 39-135) in direct and indirect costs, and the health-care system paid US$280 (IQR 150-420) per hospitalization producing an overall societal cost of US$393 (IQR 258-552). CONCLUSIONS: The cost of severe ARI to caregivers and the health care system was substantive. Our estimates will inform models to estimate national costs of severe ARI and cost-benefit of prevention and treatment strategies.


Assuntos
Efeitos Psicossociais da Doença , Hospitalização , Infecções Respiratórias/epidemiologia , Viroses/epidemiologia , Doença Aguda , Fatores Etários , Criança , Pré-Escolar , Análise Custo-Benefício , El Salvador/epidemiologia , Feminino , Gastos em Saúde , Humanos , Lactente , Recém-Nascido , Masculino , Panamá/epidemiologia , Aceitação pelo Paciente de Cuidados de Saúde , Vigilância em Saúde Pública , Fatores Socioeconômicos
4.
JMIR Public Health Surveill ; 3(4): e87, 2017 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-29138128

RESUMO

BACKGROUND: In many Latin American countries, official influenza reports are neither timely nor complete, and surveillance of influenza-like illness (ILI) remains thin in consistency and precision. Public participation with mobile technology may offer new ways of identifying nonmedically attended cases and reduce reporting delays, but no published studies to date have assessed the viability of ILI surveillance with mobile tools in Latin America. We implemented and assessed an ILI-tailored mobile health (mHealth) participatory reporting system. OBJECTIVE: The objectives of this study were to evaluate the quality and characteristics of electronically collected data, the user acceptability of the symptom reporting platform, and the costs of running the system and of identifying ILI cases, and to use the collected data to characterize cases of reported ILI. METHODS: We recruited the heads of 189 households comprising 584 persons during randomly selected home visits in Guatemala. From August 2016 to March 2017, participants used text messages or an app to report symptoms of ILI at home, the ages of the ILI cases, if medical attention was sought, and if medicines were bought in pharmacies. We sent weekly reminders to participants and compensated those who sent reports with phone credit. We assessed the simplicity, flexibility, acceptability, stability, timeliness, and data quality of the system. RESULTS: Nearly half of the participants (47.1%, 89/189) sent one or more reports. We received 468 reports, 83.5% (391/468) via text message and 16.4% (77/468) via app. Nine-tenths of the reports (93.6%, 438/468) were received within 48 hours of the transmission of reminders. Over a quarter of the reports (26.5%, 124/468) indicated that at least someone at home had ILI symptoms. We identified 202 ILI cases and collected age information from almost three-fifths (58.4%, 118/202): 20 were aged between 0 and 5 years, 95 were aged between 6 and 64 years, and three were aged 65 years or older. Medications were purchased from pharmacies, without medical consultation, in 33.1% (41/124) of reported cases. Medical attention was sought in 27.4% (34/124) of reported cases. The cost of identifying an ILI case was US $6.00. We found a positive correlation (Pearson correlation coefficient=.8) between reported ILI and official surveillance data for noninfluenza viruses from weeks 41 (2016) to 13 (2017). CONCLUSIONS: Our system has the potential to serve as a practical complement to respiratory virus surveillance in Guatemala. Its strongest attributes are simplicity, flexibility, and timeliness. The biggest challenge was low enrollment caused by people's fear of victimization and lack of phone credit. Authorities in Central America could test similar methods to improve the timeliness, and extend the breadth, of disease surveillance. It may allow them to rapidly detect localized or unusual circulation of acute respiratory illness and trigger appropriate public health actions.

6.
Biomédica (Bogotá) ; 20(4): 308-13, dic. 2000. tab
Artigo em Espanhol | LILACS | ID: lil-278205

RESUMO

La disminución del riesgo de adquirir una enfermedad por vía transfusional se basa en la selección cuidadosa de los donantes por medio de la encuesta, el tamizaje serológico y, más recientemente, la inactivación viral. La encuesta permite detectar individuos en riesgo de portar infecciones que podrían no ser detectados en el tamizaje serológico (período de ventana); por tanto, su utilidad depende, entre otros, del tipo de donante y de sus motivaciones para donar. En algunos países, los donantes difieren de la población general en aspectos como las características sociales, la frecuencia en la donación y, principalmente, en el bajo riesgo de presentar infecciones transmisibles por sangre. En Colombia, sin embargo, cerca del 80 por ciento de la sangre proviene de donantes de reposición y muchas veces obligados, que donan con poca regularidad. Con el propósito de analizar la utilidad de la encuesta, el proceso de selección de donantes y estimar la prevalencia de las infecciones transmitidas por sangre tamizada, se realizó un estudio descriptivo de los registros de donantes que acudieron en noviembre y diciembre de 1996 a un banco de sangre de Bogotá. Se revisaron 414 encuestas de donantes y sus resultados serológicos correspondiente. Se analizó si la encuesta incluía o no preguntas sobre factores de riesgo para infecciones susceptibles de trasmitirse por sangre, el porcentaje de preguntas con respuesta en todos los casos, la concordancia entre las respuestas del donante y el procedimiento realizado, ya fuera aceptando o no la donación, las características sociodemográficas y finalmente, se estimó la reactividad a anticuerpos contra VIH, VHC, Treponema pallidum, Trypanosoma cruzy y contra HBsAg. Se encontró que las preguntas sobre antecedentes de tatuaje, uso de drogas intravenosas y tipo de conducta sexual, entre otras, no estaban incluidas en la encuesta. El 90 por ciento de las preguntas fue diligenciado en las 414 encuestas; las preguntas sobre sexo, ocupación y estado civil presentaron el mayor porcentaje sin respuesta. 65 por ciento de los donantes eran hombres. El promedio de edad fue de 32 años. Del total de donantes, 325 (78,5 por ciento) no informaron ningún factor de riesgo para la donación en su encuesta y de éstos, 52 (16 porciento)...


Assuntos
Humanos , Bancos de Sangue , Doadores de Sangue/classificação , Coleta de Dados , Medição de Risco , Transfusão de Sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...